ES2076190T3 - Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv. - Google Patents

Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv.

Info

Publication number
ES2076190T3
ES2076190T3 ES89120396T ES89120396T ES2076190T3 ES 2076190 T3 ES2076190 T3 ES 2076190T3 ES 89120396 T ES89120396 T ES 89120396T ES 89120396 T ES89120396 T ES 89120396T ES 2076190 T3 ES2076190 T3 ES 2076190T3
Authority
ES
Spain
Prior art keywords
piridone
hiv
medication
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89120396T
Other languages
English (en)
Inventor
Genkichi Ohta
Mitsuru Furusawa
Junko Nozaki
Takashi Iino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2076190T3 publication Critical patent/ES2076190T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICION DE VIRUS DE INMUNODEFICIENCIA ANTIHUMANO QUE CONSTA DE UN DERIVADO DE ACIDO PIRIDONACARBOXILICO QUE CONTENGA FLUOR COMO INGREDIENTE ACTIVO Y UN SOPORTE FARMACEUTICAMENTE ACEPTABLE.
ES89120396T 1989-04-28 1989-11-03 Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv. Expired - Lifetime ES2076190T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11080089 1989-04-28
JP19106289 1989-07-24

Publications (1)

Publication Number Publication Date
ES2076190T3 true ES2076190T3 (es) 1995-11-01

Family

ID=26450330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89120396T Expired - Lifetime ES2076190T3 (es) 1989-04-28 1989-11-03 Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv.

Country Status (12)

Country Link
EP (1) EP0394553B1 (es)
KR (1) KR900015733A (es)
AT (1) ATE123945T1 (es)
AU (1) AU638421B2 (es)
CA (1) CA2002137A1 (es)
DE (1) DE68923169T2 (es)
DK (1) DK545889A (es)
ES (1) ES2076190T3 (es)
HU (1) HU205717B (es)
IE (1) IE69269B1 (es)
IL (1) IL92187A (es)
NZ (1) NZ231246A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0470252A4 (en) * 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
US5308854A (en) * 1990-06-18 1994-05-03 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
JPH05117150A (ja) * 1991-10-25 1993-05-14 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
CA2152828A1 (en) * 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
CA2194435A1 (en) * 1994-07-18 1996-02-01 Ube Industries, Ltd. Trifluoromethylquinolinecarboxylic acid derivative
UA72207C2 (uk) 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6664267B1 (en) 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
WO2005023805A1 (en) 2003-09-04 2005-03-17 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202822A (ja) * 1984-03-28 1985-10-14 Dai Ichi Seiyaku Co Ltd 抗ウイルス薬
DE3420116A1 (de) * 1984-05-30 1985-12-05 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
EP0470252A4 (en) * 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug

Also Published As

Publication number Publication date
AU638421B2 (en) 1993-07-01
DK545889D0 (da) 1989-11-02
EP0394553A3 (en) 1992-12-09
ATE123945T1 (de) 1995-07-15
NZ231246A (en) 1997-06-24
CA2002137A1 (en) 1990-10-28
EP0394553B1 (en) 1995-06-21
DE68923169D1 (de) 1995-07-27
HUT53523A (en) 1990-11-28
KR900015733A (ko) 1990-11-10
DK545889A (da) 1989-11-02
HU895654D0 (en) 1990-01-28
IE893528L (en) 1990-10-28
IE69269B1 (en) 1996-08-21
EP0394553A2 (en) 1990-10-31
AU4434189A (en) 1990-11-01
IL92187A0 (en) 1990-07-26
DE68923169T2 (de) 1995-10-26
HU205717B (en) 1992-06-29
IL92187A (en) 1994-08-26

Similar Documents

Publication Publication Date Title
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
DK0727419T3 (da) Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
ES2055860T3 (es) Derivados 2-aminopirimidinona.
DE69206876D1 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
MX9201672A (es) Compuesto de pirazol piridina y procedimiento para la preparacion de los mismos.
ATE123945T1 (de) Verwendung von fluor enthaltenden pyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur behandlung von hiv infektionen.
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
FI922044A0 (fi) Ny polypeptid och daerav framstaelld hiv-medicin.
DK515489D0 (da) Dispergerbar laegemiddelformulering
DE69333723D1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
ES2173883T3 (es) Utilizacion de derivados de piperacina-acetamida contra los daños de reperfusion.
MX9303572A (es) Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
MC1930A1 (fr) Produit antiviral
ITMI920132A1 (it) Derivati della 8-(1-amminocicloalchil)1, 3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
DK0632035T3 (da) Hidtil ukendte aminoalkylchromoner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE59290T1 (de) Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids.
AR005456A1 (es) Comprimidos y tabletas farmaceuticas que contienen 2-(2-(2-amino-9h-purin-9-il)etil)-1,3-propanodiol diacetato (famcicloviri) yprocedimiento para obtenerlos
ES2040783T3 (es) Procedimiento para preparar antagonistas de leucotrienos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 394553

Country of ref document: ES